Clinical Trial Update: Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial update for amphetamine extended-release tablets in adults with ADHD; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Amphetamine Extended Release Tablets

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: ADHD | Phase 3 | Status: COMPLETED | Results posted: 2023-11-02